4-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-N-(4-chlorophenyl)benzamide

Catalog No. :
ACTJIR953
CAS No. :
1092343-54-8
Molecular Formula :
C19H11Cl2F3N2O
Molecular Weight :
411.21

IUPAC Name:4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-chlorophenyl)benzamide

4-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-N-(4-chlorophenyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-N-(4-chlorophenyl)benzamide
IUPAC Name4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-chlorophenyl)benzamide
MDL No.MFCD11501679
Molecular FormulaC19H11Cl2F3N2O
Molecular Weight411.21
SMILESO=C(NC1=CC=C(Cl)C=C1)C2=CC=C(C3=NC=C(C(F)(F)F)C=C3Cl)C=C2
InChI KeyKTZYIKDGXMZXCU-UHFFFAOYSA-N
Synonym4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-N-(4-chlorophenyl)benzamide;Benzamide, N-(4-chlorophenyl)-4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-
CAS No.1092343-54-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTJIR953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTJIR953 route product structure diagram
    ACTJIR9531092343-54-8
Inquiry

2. ACTJIR953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRYNA427 route compound structure diagram
    ACRYNA427874288-02-5 In Stock
  4. Then
  5. ACTJIR953 route product structure diagram
    ACTJIR9531092343-54-8
Inquiry

Comments (0)